John N. Constantino is a board-certified child and adolescent psychiatrist and chief of behavioral and mental Health at Children’s Healthcare of Atlanta, as well as professor of psychiatry and pediatrics at Emory University School of Medicine. He is an international leader in autism trait phenotyping, sex differences in autism, and endophenotypic analyses.
John Constantino
Chief of behavioral and mental health
Children’s Healthcare of Atlanta
From this contributor
Autism is more heritable in boys than in girls
If boys have greater inherited liability for autism, the female protective effect may not fully explain the sex difference in prevalence.
Autism is more heritable in boys than in girls
Q&A with John Constantino: Solving the biomarker conundrum
Biological factors that reflect autism’s roots may differ from those that influence how severe the condition is. Failure to make a distinction has stymied the search for biomarkers.
Q&A with John Constantino: Solving the biomarker conundrum
Traits of other conditions may spur autism
Early features of other conditions may contribute to autism itself
Traits of other conditions may spur autism
Japanese spectrum
Researchers studying autism prevalence should take into account the continuous nature of autism symptoms in the general population, says John Constantino.
Explore more from The Transmitter
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.